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Prion diseases are a group of infectious, incurable, fatal neurodegenerative 
disorders, including scrapie in sheep, bovine spongiform encephalopathy in cows, 
chronic wasting disease in deer, and Creutzfeldt-Jakob disease (CJD) in humans. A key 
event in prion disease is the conformational transition of the cellular prion protein (PrPC) 
into the pathogenic isoform (PrPSC). Prion disease occurrence depends mainly on the 
interaction between the host prion protein (PrPC) and the prion strain (PrPSC). It was 
hypothesized that prion gene polymorphisms correlate with an organism’s susceptibility 
to prion disease, which may be related to the overall stability of the α-helical domain of 
the protein. Prion gene polymorphisms are also related to the species barrier between 
different mammalian species. The closer the three-dimensional conformation of the prion 
proteins in donor and recipient animals, the easier it is to transmit prion diseases between 
the two. Interestingly, some animal species are considered resistant to prion diseases, 
such as pigs, rabbits, and dogs, since no single case of naturally-occurring disease has 
been reported in them. In this research, I looked for polymorphisms in the PrPC gene by 
comparing wild pig sequences to each other, as well as other susceptible and resistant 
species. There are several regions in the nucleotide sequence in the PrPC gene of all pigs 
that are highly conserved. A key polymorphism seems to reside at position 224. This 
polymorphism might be used as a prediction tool of the animal susceptibility for prion 
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Prion diseases are group of rare, infectious, incurable, fatal neurodegenerative 
conditions (Pastore and Zagari 2007), including scrapie in sheep, bovine spongiform 
encephalopathy (BSE) in cow, chronic wasting disease (CWD) in deer (Bosque 2002), 
kuru, Creutzfeldt-Jakob, Gerstmann–Sträussler–Scheinker diseases, and fatal familial 
insomnia in humans (Imran and Mahmood 2011). Creutzfeldt-Jakob disease (CJD) is the 
most common form among human prion diseases (Knight 2017). The prevalence of 
human prion diseases is 1–2 persons per million worldwide each year (Chen and Dong 
2016). 
History of Prion Diseases 
Prion diseases have been known for more than 200 years. In 1732, scrapie was 
first reported in Spanish merino sheep (Liberski 2012). This happened when Spanish 
shepherds observed their sheep scraping themselves against the wall, a condition that was 
later called scrapie (Zabel and Reid 2015). Early in the 20th century, Hans Gerhard 
Creutzfeldt in 1913 (Conti1 2016) and Alfons Maria Jakob in 1921 identified a condition 
similar to scrapie, currently known as Creutzfeldt-Jakob disease, and was later classified 
with the transmissible spongiform encephalopathies (TSEs) (Gambetti et al, 2003).  
In humans, kuru is a prion disease that attacked the Fore tribe in the Eastern 
Highlands of Papua New Guinea (Figure 1), and to a lesser degree the surrounding tribes 
that had close relationships such as marriage (Alpers 2008). The word kuru means “to 
shake from fear”, it is derived from a Fore language phrase that describes the symptoms 
associated with this condition (Hornabrook 1975). Kuru was first recognized in the 
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1950s, however, the beginning of the first case was dated to the 1920s (Collinge et al, 
2008). The cause of kuru and the reason why this condition was associated with these 
tribes is due to their funeral ritual practices. They practiced endocannibalism as a part of 
their funeral rituals. Once a family member died, the remaining family members would 
cook and eat them (Alpers 2008). Kuru was epidemic in the period between 1957-1961, 
with about 1000 deaths. Luckily, kuru has mostly disappeared after the cessation of 
endocannibalism in the 1950s (Alpers 2008). However, kuru has a very long incubation 
period that exceeds 50 years and cases could still arise (Alpers 2008).  
In United Kingdom in 1986 the first bovine spongiform encephalopathy (BSE) 
was detected (Edinburgh 2017; Monaco 2013). BSE is thought to have resulted from 
feeding cattle meat and bone meal from scrapie-infected sheep (Orge et al, 2015). In 
1993, one hundred twenty thousand cattle were diagnosed with BSE, two years later three 
human victims were infected with variant Creutzfeldt-Jakob disease (vCJD). In 1996, ten 
cases of vCJD in people were reported, at this point, the United Kingdom government 
admitted that BSE can be transmitted to humans, and this outbreak forced the government 
to destroy 4.5 million cattle (Edinburgh 2017; Monaco 2013). 
Causative Agent of Prion Diseases 
Prions are proteinaceous infectious particles that are free of nucleic acid and 
resistant to inactivation by most methods that destroy or change nucleic acids (Zabel and 
Reid 2015). The causative agent is the misfolded form of the normal cellular prion 
protein PrPC into a pathogenic isoform PrPSC (Figure 2). PrPC contains 40% α-helices and 
3% β-sheets, however, PrPSC consists of 30% α-helices and 40% β-sheets (Figure 2) 
(Aguzzi and Calella 2009).  
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Unfortunately, the precise function of PrPC is unknown; however, scientists have 
suggested several important roles. These include copper transportation into cells, 
protection of nerve cells from injury, communication between neurons (Wulf et al, 2017), 
and memory functions (Sakudo et al, 2011). 
PrPC is a host-encoded glycoprotein that is anchored to the plasma 
membrane via a glycosylphosphatidylinositol (GPI) anchor (Pastore and Zagari 2007). 
The human PrP gene encodes a protein composed of 253 amino acids (Pastore and Zagari 
2007). Twenty-two amino acid residues are lost post-processing, resulting in 231 residues 
total (Rodriguez et al, 2017). Prion proteins are highly conserved among mammals 
(Figure 3) (Wulf et al, 2017). Human PrPC has 94.9% identity with sheep PrPC, 99.2% 
with chimpanzee PrPC, and 92.8% with cow  PrPC (Pastore and Zagari 2007). 
PrP is divided into two distinct regions with different structural and functional 
properties: the flexible N‑terminal region up to residue ~120 and the structural C-
terminal region. The N‑terminal region contains variable numbers of octapeptide 
PHGGSWGQ repeats that differ among organisms, followed by a glycine-alanine rich 
segment (Rodriguez et al, 2017). The C-terminal area consists of a globular fold of three 
α‑helices and two β- sheets. It starts with a short β-strand that leads to the first α-helix, 
then another short β-strand, which is followed by a short turn that leads to the remaining 
α-helixes (Rodriguez et al, 2017). The C-terminal portion of the prion protein is attached 
to the membrane through the GPI anchor (Figure 4) (Rodriguez et al, 2017).  
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The primary structures of PrPC and PrPSC are the same, they have the same amino 
acid sequence. However, they have different secondary and tertiary structures, which 
allows them to possess different physicochemical properties and functions (Yi et al, 
2018). PrPSC is highly resistant to inactivation, for instance, sterilization methods that are 
used for bacteria and viruses such as alcohol, autoclaving at 121oC for 20 minutes and ϒ-
ray irradiation are not effective for prion inactivation (Sakudo et al, 2011). Prion 
inactivation requires special treatment, such as autoclaving under severe conditions of 
134˚C for 18 minutes, NaOH (1 N, 20˚C, 1 h),  sodium dodecyl sulfate SDS (30%, 
100˚C, 10 min), or NaOCl (20000 ppm, 20˚C, 1 min) is recommended (Sakudo et al, 
2011). 
The misfolded form also shows resistance to proteolytic enzymes, exposing PrPSC to 
proteolytic enzymes will result in N terminal digestion up to residues 81-95, depending 
on the strain (Kupfer et al, 2009). Increased resistance to proteolytic enzymes tends to 
increase the aggregation ability of PrPSC segments (Kupfer et al, 2009).   
The formation and propagation of the abnormal prion protein is thought to be 
through the misfolding of the cellular prion protein, followed by aggregation and 
deposition of misfolded form within the cells. The aggregated protein recruits and 
converts further cellular prion protein. The misfolded protein builds up in the brain, 
damaging the neurons, and producing microscopic sponge-like vacuoles in the brain. 
(Kupfer et al, 2009). The actual process of how this misfolding and recruiting occurs is 
still unknown (Pezza and Serio 2007). 
Prion diseases can be classified into familial, sporadic, or acquisition by infection 
(Gambetti et al, 2003). All forms share the pathogenic mechanism in which the cellular 
5 
 
prion protein converts into the misfolded form (Gambetti et al, 2003). The cause of 
sporadic Creutzfeldt-Jakob disease (sCJD) is unknown, however the familial forms such 
as fatal familial insomnia (FFI) and Gerstmann–Sträussler–Scheinker syndrome (GSS) 
are associated with mutations of the prion protein gene (PRNP), which encodes 
PrPC  (Gambetti et al, 2003). There are more than twenty mutations of PRNP that are 
linked to prion disease. For example, a known polymorphism is located at codon 129, 
either encodes for methionine or valine, and affects the susceptibility to sporadic or 
acquired TSEs, as well as the age of onset of the disease. Therefore, amino acid 
mutations might alter the stability of PrPC, as well as its ability to interact and form 
amyloid plaques (Kupfer et al, 2009). The acquired form of prion disease is caused by the 
transmission of infectious prion particles as in case of kuru, BSE, chronic wasting disease 
(CWD), and scrapie (Gambetti et al, 2003). In humans 85–90 % of CJD cases occur 
sporadically, 10 % of CJD cases are familial, and the acquired CJD is observed in 2–5 % 
of the cases (Chen and Dong 2016). 
Pathogenesis of Prion Diseases 
Prion diseases are devastating and untreatable conditions. The exact pathogenesis 
process and the infectious nature of prion agents are not yet completely understood. 
Protein Misfolding Cyclic Amplification (PMCA) and the Real Time Quaking-Induced 
Conversion (RT-QuIC) enable in vitro amplification and assessment of prion agents 
(Schmitz et al, 2016). The PMCA method enables in vitro amplification of PrPSC from a 
small quantity of PrPSC as a seed by sequential cycles of incubation and sonication 
(Sakudo et al, 2011). PMCA is considered the most sensitive method for detecting PrPSC 
reported so far (Sakudo et al, 2011). 
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A key event in prion disease pathogenesis is the conversion of normal cellular 
prion protein into partially protease-resistant prion protein (White and Mallucci 2009). 
However, the mechanism by which prions use to reach the central nervous system and 
replicate is still not well understood.  
The nasal cavity, oral cavity, and gastrointestinal tract are all-natural routes for 
prion exposure. The immune system always works to eliminate any detectable microbes 
such as bacteria or viruses, however, in prion disease it seems that the immune system is 
playing a role in the pathogenesis and the transmission of the misfolded protein into the 
nervous system (Zabel and Avery 2015).  
Following oral ingestion of prion containing food, prion infectious agents 
accumulate in the gut-associated lymphoid tissues (GALT), such as the Peyer's patches. 
This occurs by the help of specialized epithelial cell called microfold (M) cells, that are 
found in the mucosal immune system of the gastrointestinal tract, tonsils, upper and 
lower airways, and the conjunctiva of the eye (Gebert and Pabst 1999). M cells act as an 
antigen sampling system, which samples the lumen content and transports the antigen 
from the lumen to the cells of the immune system (Takakura et al, 2011). As any other 
pathogen, prions are transported into the antigen-presenting cells such as macrophage and 
dendritic cells (Takakura et al, 2011). Unfortunately, antigen-presenting cells will not 
fully digest prions. Prions escape antigen-presenting cells into the lymphatic system 
through the lymph fluid (Takakura et al, 2011). Then prions use the nerve endings of the 
peripheral nervous system to infect the central nervous system through retrograde 
transmission (Zabel and Avery 2015).  
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The role of the adaptive immune system, which specifically attacks and forms 
memory cells that work in cases of recurrent infections, has not been detected. No 
antibodies have been found for prion infectious agents (Zabel and Avery 2015). The 
absence of humoral immunity is due to the negative selection that eliminates B and T 
cells that recognize normal prion protein as self-antigen (Zabel and Avery 2015). Since 
the misfolded and normal forms of the prion protein share the same amino acid sequence, 
the misfolded form is also ignored by the adaptive immunity (Zabel and Avery 2015).  
Upon prion arrival into the central nervous system, prion agents will transform 
PrPC into PrPSC(Sakudo et al, 2011). This transformation will be followed by PrPSC 
aggregation in different parts of the nervous system. Deposition of PrPSC leads to the 
pathological features of prion diseases, such as neuronal cell loss, vacuolation, 
astrocytosis, and amyloid plaques (Figure 5) (Sakudo et al, 2011). These features are 
followed by the appearance of symptoms and signs (White and Mallucci 2009). 
Signs and Symptoms of Prion Diseases 
Prion diseases represent a group of conditions with strain-specific clinical signs. 
Clinical signs are variable in different breeds, flocks, regions, countries, prion strains, and 
the stages of the disease (Sakudo et al, 2011).  Different strains affect different areas of 
the brain, for example, prions attack the cerebral cortex in CJD, cerebellum in GSS, and 
thalamus in FFI (Sakudo et al, 2011). The clinical phase progresses slowly over several 
weeks to months. It usually attacks the central nervous system, resulting in progressive 
neuronal degeneration and neuronal vacuolation (Prusiner 1998). Not all symptoms are 
always present, but usually at least one or more signs are noticeable. Prion diseases result 
in depression, cardiac arrhythmia, memory loss, head tremor, teeth grinding, 
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hyperresponsiveness, anxiety, excessive salivation, aggressiveness, pruritus, cannibalism 
and biting, gait or limb ataxia, and visual signs (field defects, distortion, cortical 
blindness) (Groschup 2013). These signs usually appear in adulthood and get worse with 
time, and ultimately lead to death (Groschup 2013). However, that is not always the case; 
sporadic CJD can appear in younger people as well. 
Prions also can attack systems other than the nervous system. For instance, it has 
been found that the loss of prion protein is associated with insulin resistance and obesity 
(de Brito et al, 2017). 
Species Barriers of Prion Diseases  
The protein-only hypothesis of prion disease explains how a mismatch of prion 
protein sequences for different mammals modulates the species barriers for prion 
transmission. The tertiary structure of PrPC is conserved among mammals (Wulf et al, 
2017). Sequence similarities are 88-93% between human, bovine, and porcine prion 
proteins (Hammarstrom and Nystrom 2015).  
The species barrier in prion diseases reflects the difficulty of the disease to be 
transmitted from one species to another and cause disease (Wen-Quan Zou 2013). 
Transmission depends on the potential for exogenous PrPSC and endogenous PrPC to 
interact, where interaction relies on the conformational compatibility between the two 
proteins (Priola 2013). Prions can be transmitted within and among species. Intraspecies 
transmission of prion diseases naturally occurs, but with variable degrees. For instance, 
sheep scrapie can be transmitted both vertically and horizontally via placental tissue, 
which is considered the common route for prion transmission within a sheep flock. In this 
manner, prions in a single sheep can transmit the infection to 30–40% of the flock  
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(Priola 2013). In chronic wasting disease in deer, shedding of the infectious agents in 
saliva, feces, and urine results in highly efficient spreading of the prion, with up to 100% 
of the deer becoming infected in a herd (Priola 2013). On the other hand, sporadic 
Creutzfeldt–Jakob disease in humans has detectable infectivity in the central nervous 
system (CNS) only; its transmission requires either ingestion of part of the nervous 
system or iatrogenic transmission (Priola 2013).  
Intraspecies transmission is easier than interspecies transmission of prions. 
Species barriers in prion diseases are very strong, there is not a single case of naturally 
occurring prion disease such as sheep scrapie, CWD or sCJD, that has crossed the species 
barriers under normal conditions. Crossing the species barrier requires human 
intervention (Priola 2013). For instance, changes in the rendering process of ruminant 
carcasses to make meat and bone meal resulted in a successful crossing of  the species 
barrier for prions between sheep and cattle, which is the most favored hypothesis for the 
origin of BSE (Priola 2013). 
Species barriers to prion infection were identified by running experimental 
inoculations of different prion strains into different mammalian species, (Figure 6). For 
example, mink prion can be transmitted to hamsters but not mice, and mice are 
susceptible to mouse prion but highly resistant to hamster prion (Priola 2013). 
Mice expressing hamster prion protein are susceptible to hamster scrapie. 
Transgenic mice expressing chimeric mouse/hamster prion protein showed a region of 
prion protein that has a major role in the transmission of hamster scrapie to mice. When 
amino acid residues 108 to 189 were derived from hamster, mice were susceptible to 
hamster prion disease (Priola 2013). However, when the sequence was derived from 
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mouse prion protein, mice were resistant to hamster scrapie infection (Priola 2013). Mice 
and hamster prion proteins are very similar, they differ in only three amino acids in the 
region from codon 108 to 189, thus one of these amino acids contributes to the species 
barrier (Figure 7) (Priola 2013). 
Polymorphisms in the amino acid sequences between the species influences 
animal susceptibility as well as the species barrier. For example, mice expressing human 
prion protein are less susceptible to variant Creutzfedt-Jakob disease compared to 
sporadic Creutzfedt-Jakob disease (Hill et al, 1997). In another experiment, chronic 
wasting disease prions were not transmissible to mice expressing human prion protein. 
On the other hand, they were highly transmissible to mice expressing cervid prion protein 
(Kurt and Sigurdson 2016). Four single nucleotide polymorphisms in the prion protein 
gene were observed in pigs, one of them a single nucleotide substitution, resulted in a 
serine to asparagine amino acid substitution (Meng et al, 2005). 
The question is how does a single amino acid difference result in a completely 
different secondary and tertiary structure? Certain amino acids tend to induce the 
misfolding more often than others (Kupfer et al, 2009). Hydrophobic interaction plays an 
important role in β-sheet formation since it brings polypeptide chains into close 
proximity; moreover the presence of hydrophobic amino acids in intermediate state tends 
to form aggregations, which may lead to initiation of disease (Kupfer et al, 2009).  
Misfolding and aggregation can be initiated without the presence of infectious 
prion agents, which is exactly what happens in genetic and sporadic prion disease cases 
(Kupfer et al, 2009). Physiological conditions, such as salt concentrations and pH, are 
other possible factors that facilitate protein misfolding (Kupfer et al, 2009). For instance, 
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spider silk protein showed rapid refolding upon the reduction in sodium concentration, 
increase in potassium concentration and drop in the pH (Kupfer et al, 2009). 
Pigs are considered resistant to prion disease since no single case of naturally 
occurring prion diseases has been reported yet. However, some recent in vitro studies did 
show that pigs can be infected with different prion strains. For example, scientists tried to 
investigate the susceptibility of swine to the CWD agent following oral or intracranial 
inoculation of the prion agents. Four out of ten intracranially inoculated pigs and one out 
of ten orally inoculated pigs were positive for prion infection (Hedman et al, 2016). In 
vitro, pigs were susceptible to both BSE and sheep-derived BSE (sheep that were 
experimentally infected by intracerebral inoculation with the BSE agent) (Hedman et al, 
2016). Interestingly, the transmission of sheep-derived BSE was more efficient than the 
original cattle-BSE isolate in a transgenic mouse model expressing porcine prion protein. 
(Hedman et al, 2016).  
The main goal of this research was to sequence the prion protein gene isolated from pig 
tissues and search for polymorphisms. And correlate the polymorphisms to the animal 
susceptibility for prion diseases. Subsequently, the sequences were compared with other 
prion disease susceptible and non-susceptible mammals. Because pigs live in close 
proximity to humans and though there are no naturally reported pig prion disease, 









MATERIALS AND METHODS 
 
Sample Collection  
 A total of 35 feral pigs (Sus scrofa) tail samples were obtained from hunters in 
two different locations in Texas, United States. Pig tails were placed in 70% ethanol and 
kept at -20°C freezer to DNA extraction. 
Genomic DNA Extraction 
I used the DNeasy Blood and Tissue kit from Qiagen (Hilden, Germany) to isolate 
whole genomic DNA from each sample. The instructions from the manufacturer were 
followed as described. DNA quality and quantity were evaluated using a Nanodrop 
spectrophotometer (Nanodrop Technologies, Wilmington, DE). 
Polymerase Chain Reaction (PCR) 
Using the extracted pig genomic DNA as the template, I used PCR with 
previously published primers to amplify the prion gene (Martin et al, 1995). DNA was 
amplified using Phusion High Fidelity PCR kit obtained from New England Biolabs Inc. 
(Ipswich, MA). Martin et al. (1995) PCR protocol was followed for all the steps except 
the annealing temperature. A Fifty microliter PCR reactions were carried out in 0.5 mL 
tubes, each tube containing 0.5 µL Phusion polymerase, 1 µL of 10 mM dNTPs, 2 µL of 
template DNA, 2.5 µL each of 10 µM PrP forward 
(5’CATTTGATGCTGACACCCTCTTTA3’) and reverse 
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(5’ATGAGACACCACCACTACAGGGCT3’) primers, 10 µL of 5X Phusion High 
Fidelity Buffer, and 31.5 µL of deionized water.  
PCR cycling and running parameters were set up as the following: initial 
denaturation at 98 oC for 30 seconds, followed by 30 cycles of denaturation at 98 oC for 
10 seconds, annealing at 60 oC for 30 seconds, and extension at 72 oC for 30 seconds. 
Ultimately, final elongation was at 72 oC for 10 minutes. 
Agarose Gel Electrophoresis, PCR Purification, and Sequencing 
 Gel electrophoresis was used for assessment of the PCR products. TAE buffer 
was used to prepare 1% agarose gels (Agarose low EEO, Thermo Fisher Scientific, 
Waltham, MA). Sybersafe stain was obtained from Invitrogen and used for gel staining 
(Carlsbad, CA). The one Kb DNA ladder, obtained from Promega, (Madison, WI), was 
used to verify PCR product size, and the loading dye used was from GelPilot. PCR 
products were submitted to Genewiz (South Plainfield, NJ), for clean-up and nucleotide 
sequencing. 
Analysis 
Comparison of the nucleotide and amino acid sequences was done within wild 
pigs and among other mammalian species was done. Using BLAST tool of National 
Center for Biotechnology Information (NCBI), different amino acid sequences were 
obtained for the prion protein gene. These sequences included different mammalian 
species (Figure 11). MEGAX software (Tamura et al, 2007) and Unipro UGENE 
(Okonechnikov et al, 2012) were used to align different sequences, either nucleotide or 
amino acid. Clustal W was used, based on the length of the sequences, for the alignment. 
Identifying prion protein domains was done using Inter pro (Mitchell et al, 2019; Jones et 
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al, 2014). The three-dimensional structure of swine prion protein was obtained using 
SWISS-MODEL website (Waterhouse et al, 2018; Benkert et al, 2011; Bertoni et al, 
2017). A neighbor-joining tree was constructed for the amino acid sequences, using 


























Prion Protein Gene Detection by PCR 
I was able to isolate and amplify the prion protein gene by PCR (Figure 8). Based 
on the sequences obtained from Genewiz, nucleotide sequences of length 774 base pairs 
were obtained, and those sequences were translated into amino acid sequences of 257 
residues long. However, eight samples showed either no priming or poor-quality 
sequences. 
Multiple Alignment of the Amino Acid Sequence 
Multiple amino acid sequence alignment, for 27 feral pigs sequences and 25 
different mammalian species sequences were aligned using MEGAX software (Tamura et 
al, 2007) and Unipro UGENE (Okonechnikov et al, 2012).  The prion protein gene is 
highly conserved among mammalian species. However, polymorphisms were observed at 
different locations. One of the key positions is the polymorphism of the amino acids at 
position 224. All sequences located above the line in Figure 9 including 27 feral porcine 
samples, are resistant mammalian species and have lysine, except for rabbit samples that 
have glutamine instead. All sequences below the line in Figure 9 are susceptible and have 
arginine at position 224 (Figure 9).  
Another interesting polymorphism of the amino acid sequence is located at 
position 230. Here, all susceptible animals have tyrosine, however, most resistant animals 
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have either alanine or tyrosine (Figure 9). However, most of the resistant animal has 
alanine instead of tyrosine at position 230. 
 One organism from those that are resistant and has tyrosine is rabbit. 
Interestingly, rabbits have tyrosine, but the previous residue located at position 229 is 
alanine, which is the only organism that has alanine instead tyrosine, of the three 
sequences directly above the line (Figure 9).  In other words, positions 229 and 230 in 
resistant animals have one polar and the other non-polar amino acid, however, in resistant 
animals both are polar, except for fox and dogs. This means that position 224 is more 
reliable in determining whether an animal is resistant or susceptible, based on the amino 
acid sequence (Figure 9). 
Phylogenetic Tree  
The neighbor-joining tree was obtained using MEGAX software (Saitou and Nei 
1987; Kumar et al, 2018; Zuckerkandl and Pauling 1965) . The best fit substitution model 
is JTT +G. The branch length signifies the rate of nucleotide substitutions.  
A molecular phylogenetic tree of the amino acids clusters susceptible animals 
such a sheep, goat, cat, and deer together and the resistant animal such as pig, horse, dog, 
donkey and rabbit together, except camel which seems closer to the resistant animals, as 











The prion protein is highly conserved among mammalian species; however, some 
mammals are susceptible and others are resistant to infections by prion diseases (Pastore 
and Zagari 2007). In prion diseases, the symptoms are caused by the transition of several 
of the α-helices in the normal form of the protein to β-sheets in the pathogenic form 
(Kupfer et al. 2009) (Figure 2). Resistance to prion diseases then may be related to the 
overall stability of the α-helical domain of the protein. The more resistant the α-helices 
are to transitioning to β-sheets, the more resistant the animal to prion disease. This is also 
related to the species barrier between different mammalian species. The closer the three-
dimensional conformation of the prion proteins in donor and recipient animals, the easier 
it is to transmit prion diseases between the two (Moore et al, 2005). 
There are several regions in the nucleotide sequence in the PrPC gene of all pigs 
that are highly conserved.  Four octapeptide repeats were observed in all animals in the N 
terminal region. Rabbit, human, and camel sequences have a deletion mutation within the 
fourth repeat (Figure 11).  
I was able to identify three conserved domains in the pig prion protein using Inter 
pro (Mitchell et al, 2019; Jones et al, 2014). These were amino acid residues 1 – 30, 117 
– 132, and 138 – 254. In the first and second domains there were not any interesting 
polymorphisms, on the other hand the third domain, residues 138 – 254, has an 
interesting polymorphism. Polymorphism at position 224 is conserved in the susceptible 
as well as the resistant animals. As mentioned earlier, all susceptible animals have 
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arginine and all resistant animals have lysine except rabbits, which have glutamine. This 
domain consists of the first α-helix 144-156, the second short β-strand 160-164, the 
second α-helix 174-193, and the final α-helix 199-229 (Rodriguez et al, 2017). 
Interestingly, amino acid residues in the 199 to 229 region also maps to the last α-helical 
domain of prion protein (Figure 9) (Rodriguez et al, 2017). 
Amino acid residues differ in their helix-forming potential, with methionine, 
alanine, leucine, glutamate, and lysine having a tendency to be part of α-helix structures 
and are helix-stabilizing residues. Linear side chains with two, three, or four carbons are 
strongly helix-stabilizing (Lyu et al, 1991). The polymorphism observed in this work 
confers stability to this region, providing evidence of the effect of polymorphisms on 
animal susceptibility to prion (Leiro et al, 2017). 
Another amino acid polymorphism is the combination of position 229 and 230, 
most susceptible animals have two aromatic amino acid residues. aromatic amino acid 
such as tyrosine has a large side chain, the presence of two tyrosine residues next to each 
other and subsequently two large side chains is unfavorable for α-helices formation. 
However, resistant animals have a combination of tyrosine or another aromatic amino 
acid and amino acid other than aromatic residues, the combination of tyrosine and alanine 
is more favorable since alanine has a very small side chain compared to tyrosine, this 
interaction is preferable for α-helices formation. Moreover, the presence of two aromatic 
amino acid residues result in the formation of pi-stacking that results in β-sheet 
formation. 
 One exception is in the canines, including dogs and foxes. The interesting 
observation in canines is that they have polymorphisms in positions that are highly 
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conserved in resistant and susceptible animals. For example, at position 219 all animals 
have isoleucine, except canines have valine. Also, at 181, canines have arginine instead 
of histidine. This change is important, although both residues are basic, histidine is 
neutral at physiological pH. At position 163, canines have aspartic acid instead of 
asparagine, at 107 they have asparagine instead of serine (Figure 12). Many factors play a 
role in protein structure, such as whether amino acid residues are basic, acidic, polar, or 
non-polar. Their interactions and locations to each other are also important. For instance, 
non-neighbor amino acids may interact and affect the structure of the protein. In the prion 
protein, amino acids 149, 208, and 212 are very close to each other and their interactions 
affect the overall structure. Similarly, this is also observed for residues 119, 120, 156, and 
193 (Figure 13). This means these polymorphisms in canines may interact and stabilize 
the normal prion protein, preventing it from misfolding. Moreover, some of these 
polymorphisms are located in α-helices, such as polymorphism 181 located in the second 
α-helix (residues 174-193), and polymorphism 219 located within the last α-helix 
(residues 199-229).  
The molecular phylogenetic tree (Figure 10) represents the evolutionary 
relationships among groups of organisms. The tree is divided into two main clades, in the 
first clade all organisms are pigs, either from feral pigs or pig sequences from NCBI. The 
second clade consists of both prion-resistant and susceptible organisms. The resistant 
animals such as horses, dogs, and foxes are grouped together and are closer to the pigs’ 








Prion disease is a serious condition. The conversion of the cellular prion protein 
(PrPC) into the pathogenic isoform (PrPSC) is a crucial step (Westergard et al, 2007). This 
conversion is controlled by many factors such as amino acid sequence, pH, and salt 
concentration. My results showed that different vital amino acid polymorphisms can be 
used to judge the possibility for an animal to get a prion disease based on these 
polymorphisms. 
 Most mammals are susceptible, however, some are not. Pigs, horses, dogs, and 
rabbits are resistant animals. Amino acid polymorphisms located at position 224 maybe 
more diagnostic than position 230. However, combining the two positions can increase 
the confidence of the prediction of susceptibility.  
There are more than 50 protein misfolding disease including Alzheimer, 
Parkinson’s disease and prion diseases. The more we know about one of these diseases 













Figure 1: Examination of child infected with Kuru in Papua New Guinea. Children and 
women were more likely to be affected with kuru, as specific kin had specific rights to 
















Figure 2: Difference in β-sheets content in PrPC and PrPSC. This change results in 














Figure 3: Mouse prion protein PrP (residues 23–231). The C-terminal structural region 












Figure 4: Human prion protein, N-terminal and C-terminal regions. The N-terminal domain of PrP is non-structured 
region containing five octapeptide repeats, the hydrophobic region is blue color. The C-terminal globular domain contains 
two β-sheets and three α-helixes. The C-terminal region contains single disulfide bridge, two N-glycosylation sites, and 






Figure 5: Histopathological lesion, vacuolation of the central nervous system in a classic 







Figure 6: Species barriers to prion were identified by running experimental inoculation of 
different prion strains into different mammalian species. For example, mink prion can be 
transmitted to hamsters but not mice. And mice are highly resistant to hamster scrapie. 
 
 
Figure 7: Transgenic mice expressing chimeric mouse/hamster prion protein showed a 
region of prion protein that has a major role in the transmission of hamster scrapie to 
mice. When amino acid residues 108 to 189 were derived from hamster, mice were 
susceptible to hamster prion disease. However, when the sequence was derived from 














Figure 9: Multiple amino acid sequence alignment for prion protein of resistant animals, 
located above the line and susceptible animals are located below the line. Alignment was  




Figure 10: Neighbor-joining tree for amino acid sequences of different mammalian 





Figure 11: Four octa repeat (PHGGGWGQ) in prion protein for different species, some 
organisms have single amino acid deletion mutation such as human and rabbits. 





Figure 12: Prion protein polymorphisms, at position 107 all mammals have serine except 
canines, which have asparagine. Also, at position 163 canines have aspartic acid instead 
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of asparagine. At position 181 canines have arginine instead of histidine. Canines also 
have valine at position 219, where other mammals have isoleucine. Alignment was 


















Figure 13: Three dimentional structure of pigs prion protein. This figure shows non 
neighbor amino acids, for example, amino acids 149, 208, and 212 are very close to each 
other and their interaction affects the overall structure. This is similar for amino acids 
119, 120, 156, and 193. Image from SWISS-MODEL website (Waterhouse et al, 2018; 
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Appendix 2: An Institutional Animal Care and Use Committee (IACUC) 
 

